Jianfei Hu

7.3k citations
45 papers · 1.5k indexed · h-index 21
Topics
RNA modifications and cancer (8 papers)Glycosylation and Glycoproteins Research (5 papers)Bioinformatics and Genomic Networks (5 papers)

In The Last Decade

Jianfei Hu

43 papers receiving 1.4k citations

Peers

Jianfei Hu
Comparison fields: 5 of 110
  • Molecular Biology 1.0k
  • Cancer Research 402
  • Radiology, Nuclear Medicine and Imaging 141
  • Oncology 121
  • Genetics 117
Replace Stefan Kirov with:
Stefan Kirov United States
José Vázquez‐Prado Mexico
Juan Zalvide Spain
Jay Snoddy United States
Carmit Levy Israel
Zachary C. Dobbin United States
Amy N. Abell United States
Abdelali Jalil France
Robert P. Searles United States
Céline DerMardirossian United States
Jianfei Hu relative to Stefan Kirov United States Stefan Kirov's profile →
Citations per field
00.5×2.9×
Stefan Kirov · 1×
Citations per year

Countries citing papers authored by Jianfei Hu

Since Specialization
Citations

This map shows the geographic impact of Jianfei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfei Hu more than expected).

Fields of papers citing papers by Jianfei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianfei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfei Hu. The network helps show where Jianfei Hu may publish in the future.

Co-authorship network of co-authors of Jianfei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianfei Hu. A scholar is included among the top collaborators of Jianfei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfei Hu. Jianfei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 15
4 13
5 20
6 38
7 32
8 16
9 20
10 9
11 13
12 12
13 77
14 48
15 51
16 50
17 18
18 27
19 38
20 24

About Jianfei Hu

Jianfei Hu is a scholar working on Cancer Research, Molecular Biology and Animal Science and Zoology, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Glycosylation and Glycoproteins Research (5 papers) and Bioinformatics and Genomic Networks (5 papers). The work is most often cited by research in Cancer Research (402 citations), Molecular Biology (1.0k citations) and Endocrine and Autonomic Systems (65 citations). Jianfei Hu has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Jiang Qian, Heng Zhu, Seth Blackshaw, Jun Yu, Xiaoqian Zhao, Robert H. Newman, Abigail S. Hackam, Hyun Yi, Timothy W. Bredy and Darya Vanichkina. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026